Markets › LSE › 0R1F.L

Bristol-Myers Squibb Company

LSE:0R1F.LHealthcare

——At close · Market cap — · Next earnings Thu 29 Oct

Ratio	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	Current · undated	YoY
Gross margin	71.6%	69.8%	72.3%	78.6%	78.8%	76.6%	—	—
Operating margin	23.4%	23.2%	8.0%	18.5%	21.4%	19.2%	19.2%	+0.0 pts
Net margin	21.8%	13.2%	−21.2%	15.1%	13.7%	17.8%	17.8%	+0.0 pts
EBITDA margin	26.0%	29.8%	32.5%	41.7%	43.7%	40.9%	—	—
Return on equity	35.1%	6.7%	−23.8%	19.5%	20.4%	27.3%	27.2%	−0.1 pts
Return on assets	14.1%	2.6%	−7.6%	6.4%	6.5%	8.4%	8.4%	+0.0 pts
Return on capital employed	21.7%	5.4%	3.4%	9.8%	13.2%	11.9%	—	—
Debt / equity	0.0×	0.9×	1.4×	1.3×	1.3×	1.4×	1.4×	−0.2%
Debt / assets	0.0%	36.5%	43.5%	41.6%	42.0%	43.5%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	1.7×	1.6×	1.6×	1.5×	1.2×	1.4×	1.4×	+0.0%
Quick ratio	1.6×	1.4×	1.5×	1.4×	1.1×	1.3×	—	—
Cash ratio	0.6×	0.7×	0.8×	0.6×	0.4×	0.5×	0.5×	+0.0%
Asset turnover	0.6×	0.2×	0.4×	0.4×	0.5×	0.5×	—	—
Inventory turnover	5.4×	1.8×	5.7×	4.7×	4.2×	4.0×	—	—
Receivables turnover	3.9×	3.4×	4.9×	4.8×	4.4×	4.0×	—	—
Dividend payout	53.1%	77.9%	−45.2%	62.9%	73.2%	59.1%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2023 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.